Barclays Maintains an 'Overweight' on Allscripts-Misys Healthcare (MDRX); Tone Into 4Q: Focus on Eclipsys Growth, Progress on Merger Integration
Go back to Barclays Maintains an 'Overweight' on Allscripts-Misys Healthcare (MDRX); Tone Into 4Q: Focus on Eclipsys Growth, Progress on Merger Integration| Allscripts-Misys Healthcare Solution (AMEX: MDRX) | Delayed: 4.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.96 | 52 Week High | $15.78 | |||
| Open | $4.96 | 52 Week Low | $9.80 | |||
| Day High | $4.96 | P/E | N/A | |||
| Day Low | $4.96 | EPS | $-0.59 | |||
| Volume | 1,500 | |||||

